IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Abbott to Expand API Manufacturing Site in Ireland

2:32 AM MST | February 15, 2012 | Deepti Ramesh

Abbott Laboratories (Chicago, IL) says it will invest €85 million ($111 million) to expand its pharmaceutical manufacturing operations at Sligo, Ireland. The manufacturing facility at Sligo manufactures active pharmaceutical ingredients (APIs) as well as finished drug products. The expansion of the facility will be completed in 2014. The expansion will provide additional space for manufacturing operations to support Abbott’s future pharmaceutical pipeline in the therapeutic areas of virology, oncology and nephrology. The investment will result in the...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa